lornoxicam

Lornoxicam (also known as chlortenoxicam) is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class. It exhibits analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) properties. Lornoxicam acts primarily by inhibiting cyclooxygenase enzymes COX-1 and COX-2 with high potency (IC50 values of 5 nM for COX-1 and 8 nM for COX-2), thereby reducing prostaglandin synthesis involved in pain and inflammation. It does not inhibit 5-lipoxygenase activity or leukotriene synthesis. Lornoxicam may also activate the opioid neuropeptide system to exert central analgesic effects. The drug is used to treat various types of pain—especially those associated with inflammatory joint diseases such as osteoarthritis—as well as postoperative pain and sciatica[1][2][3][4][5][6]. It is available in both oral and parenteral formulations.

Brand names

XefoXefocamXafonLorcamAcabel

Other names

chlortenoxicam氯诺昔康